Article R322-106-5
The draft terms of merger are drawn up by the board of directors or management board of each of the mutual insurance companies involved in the merger. It shall contain the following particulars 1° The…
20+ full codes, 2,400+ articles translated and updated. Case law linked to every article. Read the actual text before you ask a lawyer about it — free, no login required.
20+
french codes
Fully translated
2,400+
articles in English
Updated regularly
480+
court rulings linked
Per article
Free
full access
No login required
Showing 4111–4120 of 64661 articles for “Art. R 210-5 and R 210-6”
The draft terms of merger are drawn up by the board of directors or management board of each of the mutual insurance companies involved in the merger. It shall contain the following particulars 1° The…
The intervention standards drawn up by CCI France pursuant to 2° of Article L. 711-16 concern: 1° The missions entrusted to the network's establishments by laws and regulations; 2° The network's prior…
I.-For the medicinal products of major therapeutic interest referred to in article L. 5111-4, marketing authorisation holders and pharmaceutical companies exploiting medicinal products shall, under th…
Any person intending to file a draft public offer with the Autorité des marchés financiers pursuant to Chapter III of Title III of Book IV of the Monetary and Financial Code, with a view to acquiring…
Authorisation may be suspended for a maximum of six months or withdrawn by the prefect where the domiciliation company no longer meets the conditions set out in II of article L. 123-11-3 or has not ma…
I.-The refusal of authorisation to manage a blood establishment, its renewal or the substantial modification of one of its elements is notified to the director of the health establishment or to the ad…
I.-The granting of a compassionate access authorisation is subject to the establishment by the Agence nationale de sécurité du médicament et des produits de santé of a therapeutic use and patient moni…
Where batches of investigational medicinal products come from another Member State of the European Community or party to the Agreement on the European Economic Area and are manufactured or imported in…
By way of derogation from the provisions of the first sub-section, the provisions of this sub-section apply to the manufacture and importation of investigational medicinal products.
The importing pharmaceutical establishment shall ensure that the investigational medicinal products it imports have been subjected to standards of good manufacturing practice at least equivalent to th…
Avocate au Barreau de Paris
Toque #C2396
15+ Years In French Corporate Practice
English · French · Russian
Ready When You Are
A 20–30 minute call, in English, to scope the engagement. No obligation, no preliminary fee. You will leave the call with a clear view of what the work will cover and what it will cost.
20+ full codes and 2,400+ articles in English, with the key court rulings linked to every article — free to read.
Read MoreA lawyer-reviewed report explaining how the relevant articles apply to your situation, with case-law analysis and next steps.
Read MoreScope your matter with a Paris-Bar avocate — incorporation, contracts, disputes — handled bilingually, end to end.
Read More